Search for TNF-α sensitivity degradation principles from medicinal foods - Hepatoprotective amide constituents from Thai natural medicine Piper chaba

Yakugaku Zasshi

Volumn 130, Issue 6, 2010, Pages 785-791

  Morikawa, Toshio ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Amide constituent; Hepatoprotective activity; Medicinal food; Piper chaba; Piperine; TNF sensitivity degradation activity

Indexed keywords

ANTIEPILEPSIRINE; BRACHYSTAMIDE B; CHAVICINE; DEHYDROPIPERNONALINE; FRAGARAMIDE; GUINEENSINE; ISOCHAVICINE; ISOPIPERINE; N CINNAMOYLPIPERIDINE; PIPERCHABAMIDE A; PIPERCHABAMIDE B; PIPERCHABAMIDE C; PIPERCHABAMIDE D; PIPERCHABAMIDE E; PIPERCHABAMIDE F; PIPERCHABAMIDE G; PIPERCIDE; PIPERIC ACID ISOPENTYL AMIDE; PIPERINE; PIPERLONGUMININE; PIPERNONALINE; PIPEROLEINE; PIPEROLEINE B; PIPERUNDECALIDINE; PLANT EXTRACT; PROTECTIVE AGENT; RETROFRACTAMIDE A; RETROFRACTAMIDE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL DEATH; DRUG ACTIVITY; DRUG EFFECT; DRUG SENSITIVITY; DRUG STRUCTURE; LIVER CELL; LIVER INJURY; NONHUMAN; PIPER CHABA; PIPERACEAE; PRACTICE GUIDELINE; REVIEW;

ALKALOIDS; AMIDES; ANIMALS; BENZODIOXOLES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; HEPATOCYTES; LIPOPOLYSACCHARIDES; MICE; PIPER; PIPERIDINES; POLYUNSATURATED ALKAMIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953175815     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.785     Document Type: Review

References (23)

1. Hide I., Nippon Yakurigaku Zasshi., 121, 163-173 (2003).
2. Wang Y., Singh R., Lefkowitch J. H., Rigoli R. M., Czaja M. J., J. Biol. Chem., 281, 15258-15267 (2006).
3. Tilg H., Day C. P., Nat. Clin. Pract. Gastroenterol. Hepatol., 4, 24-34 (2007).
4. Seronello S., Sheikh M. Y., Choi J., Free Radical Biol. Med., 43, 869-882 (2007).
5. Sugita T., Yakugaku Zasshi, 129, 19-24 (2009).
6. Humphreys D. T., Wilson M. R., Cytokine, 11, 773-782 (1999).
7. Uboldi A. D., Savage N., Cytokine, 19, 250-258 (2002).
8. Tewtrakul S., Hase K., Kadota S., Namba T., Komatsu K., Tanaka K., J. Essent. Oil Res., 12, 603-608 (2000).
9. Lucey M. R., Mathurin P., Morgan T. R., N. Engl. J. Med., 360, 2758-2769 (2009).
10. Morikawa T., Matsuda H., Yamaguchi I., Pongpiriyadacha Y., Yoshikawa M., Planta Med., 70, 152-159 (2004).
11. Matsuda H., Ninomiya K., Morikawa T., Yasuda D., Yamaguchi I., Yoshikawa M., Bioorg. Med. Chem. Lett., 18, 2038-2042 (2008).
12. Matsuda H., Ninomiya K., Morikawa T., Yasuda D., Yamaguchi I., Yoshikawa M., Bioorg. Med. Chem., 17, 7313-7323 (2009).
13. Morikawa T., Yamaguchi I., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 57, 1292-1295 (2009).
14. Kitagawa I., Yoshikawa M., "Shokuhinyakugaku Handbook," Kodansha Scientific Ltd., Tokyo, 2005, pp. 193-194.
15. "Natural Standard Herb & Supplement Reference: Evidence Based Clinical Reviews," eds. by Ulbricht C. E., Basch E. M., Sunchoh Publishing Co., Ltd., Tokyo, 2007, pp. 158-175.
16. Feher J., Deak G., Muzes G., Lang I., Niederland V., Nekam K., Karteszi M., Orv. Hetil., 130, 2723-2727 (1989).
17. Skottova N., Krecman V., Physiol. Res., 47, 1-7 (1998).
18. Matsuda H., Kiyohara S., Sugimoto S., Ando S., Nakamura S., Yoshikawa M., Biol. Pharm. Bull., 32, 147-149 (2009).
19. Yoshikawa M., Morikawa T., Oominami H., Matsuda H., Chem. Pharm. Bull., 57, 957-964 (2009).
20. Matsuda H., Ninomiya K., Morikawa T., Yoshikawa M., Bioorg. Med. Chem. Lett., 8, 339-344 (1998).
21. Matsuda H., Morikawa T., Ninomiya K., Yoshikawa M., Bioorg. Med. Chem., 9, 909-916 (2001).
22. Morikawa T., Matsuda H., Ninomiya K., Yoshikawa M., Biol. Pharm. Bull., 25, 627-631 (2002).
23. Yoshikawa M., Shokuhin to Kagaku, 48, 25-27 (2006).